Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -54.96% is 14% below its 5-year average of -48.32%, near the low end of its 5-year range (-67.43%–-20.67%).
As of the fiscal period ended Tuesday, June 30, 2026. 10.39% above its 12-month average of -61.34%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -54.96%.
RETURN ON EQUITY (ROE)
-54.96%
RETURN ON EQUITY (ROE) AVG TTM
-61.34%
RETURN ON EQUITY (ROE) AVG 3Y
-55.28%
RETURN ON EQUITY (ROE) AVG 5Y
-48.32%
RETURN ON EQUITY (ROE) AVG 10Y
-38.28%
RETURN ON EQUITY (ROE) AVG 15Y
N/A
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
+10.39%
CURRENT VS 3Y AVG
+0.56%
CURRENT VS 5Y AVG
-13.76%
CURRENT VS 10Y AVG
-43.58%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
11.44%
median of 92 covered companies
CURRENT VS SECTOR MEDIAN
-580.45%
vs the sector median at left
Intellia Therapeutics, Inc.
Market Cap
$1.72B
Return on Equity (ROE)
-54.96%
TTM Avg
-61.34%
3Y Avg
-55.28%
5Y Avg
-48.32%
Market Cap
$1.73B
Return on Equity (ROE)
-40.41%
TTM Avg
-45.75%
3Y Avg
-30.11%
5Y Avg
-18.95%
Market Cap
$2.14B
Return on Equity (ROE)
-56.71%
TTM Avg
-50.91%
3Y Avg
-55.48%
5Y Avg
-35.68%
Market Cap
$1.00B
Return on Equity (ROE)
-13.54%
TTM Avg
-40.81%
3Y Avg
-170.75%
5Y Avg
-114.78%
Market Cap
$2.51B
Return on Equity (ROE)
-8.00%
TTM Avg
-28.91%
3Y Avg
-27.68%
5Y Avg
-39.13%
Market Cap
$2.74B
Return on Equity (ROE)
29.28%
TTM Avg
27.86%
3Y Avg
4.54%
5Y Avg
-12.45%
Market Cap
$472.39M
Return on Equity (ROE)
-6.60%
TTM Avg
-10.82%
3Y Avg
-11.36%
5Y Avg
-7.59%
Market Cap
$459.30M
Return on Equity (ROE)
89.43%
TTM Avg
81.07%
3Y Avg
67.39%
5Y Avg
61.90%
Market Cap
$397.55M
Return on Equity (ROE)
-28.18%
TTM Avg
-0.06%
3Y Avg
10.58%
5Y Avg
10.58%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Intellia Therapeutics, Inc. (NTLA) | $1.72B | -54.96% | -61.34% | -55.28% | -48.32% |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $1.73B | -40.41% | -45.75% | -30.11% | -18.95% |
| Recursion Pharmaceuticals, Inc. (RXRX)vs › | $2.14B | -56.71% | -50.91% | -55.48% | -35.68% |
| Teladoc Health, Inc. (TDOC)vs › | $1.00B | -13.54% | -40.81% | -170.75% | -114.78% |
| Beam Therapeutics Inc. (BEAM)vs › | $2.51B | -8.00% | -28.91% | -27.68% | -39.13% |
| TransMedics Group, Inc. (TMDX)vs › | $2.74B | 29.28% | 27.86% | 4.54% | -12.45% |
| NeoGenomics, Inc. (NEO)vs › | $472.39M | -6.60% | -10.82% | -11.36% | -7.59% |
| NRC Health (NRC)vs › | $459.30M | 89.43% | 81.07% | 67.39% | 61.90% |
| Shoulder Innovations, Inc. (SI)vs › | $397.55M | -28.18% | -0.06% | 10.58% | 10.58% |
| PDS Biotechnology Corporation (PDSB)vs › | $41.03M | N/A | -285.38% | -206.98% | -151.57% |
ROE
-55.0%
ROA
-46.7%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -54.96% |
| 2026-03-31 | -63.55% |
| 2025-12-31 | -61.47% |
| 2025-09-30 | -59.57% |
| 2025-06-30 | -67.14% |
| 2025-03-31 | -67.43% |
| 2024-12-31 | -59.52% |
| 2024-09-30 | -54.26% |
| 2024-06-30 | -52.40% |
| 2024-03-31 | -46.86% |
| 2023-12-31 | -45.82% |
| 2023-09-30 | -44.58% |
| 2023-06-30 | -41.04% |
| 2023-03-31 | -36.15% |
| 2022-12-31 | -38.38% |
| 2022-09-30 | -53.58% |
| 2022-06-30 | -45.48% |
| 2022-03-31 | -38.64% |
| 2021-12-31 | -25.75% |
| 2021-09-30 | -20.67% |
| 2021-06-30 | -37.40% |
| 2021-03-31 | -27.23% |
| 2020-12-31 | -25.47% |
| 2020-09-30 | -36.50% |
| 2020-06-30 | -33.02% |
| 2020-03-31 | -44.16% |
| 2019-12-31 | -36.88% |
| 2019-09-30 | -32.77% |
| 2019-06-30 | -32.29% |
| 2019-03-31 | -32.51% |
| 2018-12-31 | -30.71% |
| 2018-09-30 | -34.28% |
| 2018-06-30 | -29.68% |
| 2018-03-31 | -25.81% |
| 2017-12-31 | -22.47% |
| 2017-09-30 | -30.79% |
| 2017-06-30 | -24.67% |
| 2017-03-31 | -18.80% |
| 2016-12-31 | -15.08% |
| 2016-09-30 | -12.06% |
| 2016-06-30 | -9.77% |
| 2015-12-31 | -18.41% |
| 2015-09-30 | -19.88% |
